069. Prognostic Factors for Intravenous Abatacept Retention in Patients Who have Received at Least One Prior Biologic Agent: 2-Year Results from a Prospective, International, Real-World Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.